EI
Eikon Therapeutics, Inc. Common Stock (EIKN)
NASDAQ·Healthcare·Biotechnology
$8.89
+4.34%
Mkt Cap $44.00M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$5.00
Range $5.00 – $5.00
Implied Upside
-43.8%
Consensus $5.00 vs current $8.89